
Ibrutinib associated cardiovascular events in a patient wearing an implanted loop recorder
Author(s) -
Daniel Rivera,
Koichi Takahashi,
Jean Bernard Durand,
Alessandra Ferrajoli
Publication year - 2021
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2021.044
Subject(s) - medicine , ibrutinib , implantable loop recorder , cardiology , atrial fibrillation , chronic lymphocytic leukemia , leukemia
Ibrutinib is a well-tolerated and effective therapy used for the treatment of chronic lymphocytic leukemia (CLL). Its use has been associated with cardiovascular events such as atrial fibrillation (Afib), hypertension, and ventricular arrhythmias. Implanted loop recorders are a useful tool in guiding the management of patients with cardiac arrhythmias.